Teligent Inc (TLGTQ)

Sector:
HEALTH CARE
Industry:
PHARMACEUTICALS
SIC:
BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)
CEO:
Jason Grenfell-Gardner
Employees:
189
105 LINCOLN AVENUE, BUENA, NJ 08310
6096971441

• *** This stock is shown as delisted in our database. *** If you think this isn't correct then please let us know

Teligent, Inc. develops, manufactures, markets, and sells generic topical, branded generic, and generic injectable pharmaceutical products in the United States and Canada. The company's topical semi-solid and liquid products are used in various applications that range from cosmetics and cosmeceuticals; and the prescription treatment of conditions, such as dermatitis, psoriasis, and eczema.

Data derived from most recent annual or quarterly report
Market Cap 16.15 Million Shares Outstanding92.817 Million Avg 30-day Volume 13.849 Million
P/E Ratio0.0 Dividend Yield0.0 EPS-0.11
Price to Revenue1.0792 Debt to Equity-2.6775 EBITDA-121.981 Million
Price to Book Value0.0 Operating Margin-296.2503 Enterprise Value159.012 Million
Current Ratio4.098 EPS Growth0.898 Quick Ratio2.584
1 Yr BETA 0.3843 52-week High/Low 0.0 / Profit Margin-197.7817
Operating Cash Flow Growth-19.5393 Altman Z-Score-7.4398 Free Cash Flow to Firm 5.803 Million
View SEC Filings from TLGTQ instead.

View recent insider trading info

Teligent Inc YCharts
Yahoo! Finance finviz
SEC Web Site SEC DEF 14A Filings

Funds Holding TLGTQ (via 13F filings)

Refresh Download CSV Download Excel (.xlsx) Download TSV
Filter by:
Click for Additional Filters
to
to
to
Refresh
*Shares are split adjusted
*Please note that if a filer hasn't submitted a 13F filing for a quarter then the filer's shares will be listed as "Sold All"

Mutual Funds Holding TLGTQ

Download CSV

Active Schedule 13D and 13G filings

Please sign in first

Recent Filings

Financial Reporting

Ownership

  • 3: filed on 2021-10-08 by BENESCH JOSEPH
  • 3: filed on 2021-10-07 by LOZYNSKI ALYSSA
  • 4: filed on 2021-07-22 by BEN-MAIMON CAROLE
  • 4: filed on 2021-07-22 by CELENTANO JOHN E
  • 4: filed on 2021-07-22 by SABATINO THOMAS J JR
  • 4: filed on 2021-07-22 by MARTH WILLIAM S
  • 4: filed on 2021-07-22 by PATE R CARTER
  • 4/A: filed on 2021-07-20 by YACHMETZ PHILIP K
  • 4: filed on 2021-07-20 by YACHMETZ PHILIP K
  • 4: filed on 2021-05-27 by PATE R CARTER

    • Events (8k)

  • 8-K: filed on 2021-10-15:
    Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers
    Item 1.01: Entry into a Material Definitive Agreement
    Item 1.03: Bankruptcy or Receivership
    Item 2.03: Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant
    Item 2.04: Triggering Events That Accelerate or Increase a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement
    Item 3.01: Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing
    Item 7.01: Regulation FD Disclosure
    Item 9.01: Financial Statements and Exhibits
  • 8-K: filed on 2021-09-27:
    Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers
  • 8-K: filed on 2021-09-24:
    Item 3.03: Material Modifications to Rights of Security Holders
    Item 5.03: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year
    Item 9.01: Financial Statements and Exhibits
  • 8-K: filed on 2021-07-22:
    Item 5.07: Submission of Matters to a Vote of Security Holders
  • 8-K/A: filed on 2021-05-07:
    Item 4.01: Changes in Registrant's Certifying Accountant
    Item 9.01: Financial Statements and Exhibits
  • 8-K: filed on 2021-05-04:
    Item 2.02: Results of Operations and Financial Condition
    Item 9.01: Financial Statements and Exhibits
  • 8-K: filed on 2021-04-22:
    Item 3.01: Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing
  • 8-K: filed on 2021-04-15:
    Item 3.01: Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing
  • 8-K: filed on 2021-04-15:
    Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers
    Item 9.01: Financial Statements and Exhibits
  • 8-K: filed on 2021-04-01:
    Item 8.01: Other Events

    • Proposed Sales (Form 144)

    Proxy

    Prospectus

    All

    Open Market Buys/Sells Last 60 Days

    Open Market Buys (P)

    none

    Open Market Sells (S)

    none

    Exercise Derivative Conversion (M)

    none

    Current/Former Insiders

    Insider Name Type Last Reported Shares Held Last Reported Date Filings in past year

    LOZYNSKI ALYSSA INTERIM CFO

    • Officer
    		 0 2021-09-23 0

    BENESCH JOSEPH VP, CONTROLLER, PAO

    • Officer
    		 0 2021-09-23 0

    SABATINO THOMAS J JR

    • Director
    		 150,000 2021-07-21 0

    CELENTANO JOHN E

    • Director
    		 150,000 2021-07-21 0

    BEN-MAIMON CAROLE

    • Director
    		 150,000 2021-07-21 0

    MARTH WILLIAM S

    • Director
    		 150,000 2021-07-21 0

    PATE R CARTER

    • Director
    		 150,000 2021-07-21 0

    YACHMETZ PHILIP K EVP, CHIEF LEGAL OFF, CORP SEC

    • Officer
    		 28,681 2021-07-16 0

    DE PAOLANTONIO ERNEST ROBERT CHIEF FINANCIAL OFFICER

    • Officer
    		 435,000 2021-04-15 0

    SAWYER TIMOTHY B. CHIEF EXECUTIVE OFFICER

    • Officer
    • Director
    		 1,000,000 2021-03-11 0

    KOEHLER STEVEN H

    • Director
    		 0 2021-01-04 0

    CHAUDHURI BHASKAR

    • Director
    		 0 2021-01-04 0

    JAMES KEITH PRIN ACCT OFFICER CONTROLLER

    • Officer
    		 0 2020-10-08 0

    LIFE SCIENCES OPPORTUNITIES FUND INSTITTUTIONAL II LP

    LIFE SCIENCES OPPORTUNITIES FUND II LP

    SIGNET HEALTHCARE PARTNERS, LLC

    GALE JAMES C

    SANDERS DON A

    MORRIS BEN T

    WEIR DONALD V

    • Director
    • 10% Owner
    		 No longer subject to file 2020-08-19 0

    FINIO DAMIAN CFO

    • Officer
    		 0 2020-03-02 0

    GALE JAMES C

    • Director
    		 0 2020-01-02 0

    GRENFELL-GARDNER JASON PRESIDENT & CEO

    • Officer
    • Director
    		 119,849 2019-05-23 0

    RICHARDSON STEPHEN CHIEF SCIENTIFIC OFFICER

    • Officer
    		 0 2019-02-19 0

    WILSON MARTIN GENERAL COUNSEL

    • Officer
    		 0 2019-02-19 0

    COLLINS JENNIFFER CFO

    • Officer
    		 19,206 2017-11-08 0

    BORKAR NARENDRA N

    • Director
    		 0 2017-01-03 0

    LIFE SCIENCES OPPORTUNITIES FUND II LP

    LIFE SCIENCES OPPORTUNITIES FUND INSTITTUTIONAL II LP

    GALE JAMES C

    LOF PARTNERS LLC

    SANDERS DON A

    MORRIS BENJAMIN T

    • Director
    • 10% Owner
    • SEE REMARKSSEE REMARKSSEE REMARKS
    		 10,053,308 2014-09-02 0

    ERONY JOYCE

    • Director
    		 No longer subject to file 2014-06-09 0

    HEMRIC MICHAEL B.

    • Director
    		 0 2014-01-02 0

    LAWRENCE NADYA EXEC. VP-SALES & MARKETING

    • Officer
    		 21,270 2012-05-11 0

    HAGER JANE E

    • Director
    		 0 2012-01-03 0

    MOORE CHARLES E PRESIDENT AND CEO

    • Officer
    		 0 2011-02-07 0

    HAGER EDWARD B

    • 10% Owner
    		 No longer subject to file 2010-12-31 0

    LIFE SCIENCES OPPORTUNITIES FUND II LP

    LIFE SCIENCES OPPORTUNITIES FUND INSTITTUTIONAL II LP

    LOF PARTNERS LLC

    SANDERS MORRIS HARRIS GROUP INC

    SMH CAPITAL INC.

    GALE JAMES C

    ERONY JOYCE

    BALL GEORGE L

    • Director
    • 10% Owner
    		 13,310,657 2010-08-20 0

    GERARDI FRANK

    • 10% Owner
    		 No longer subject to file 2010-08-11 0

    HAGER JANE E

    HAGER EDWARD B

    • Director
    • 10% Owner
    		 0 2010-03-29 0

    FORTE PHILLIP S CHIEF FINANCIAL OFFICER

    • Officer
    		 160,000 2010-02-12 0

    ODONNELL TERRENCE

    • Director
    		 200,520 2009-07-02 0

    MORRIS STEVE

    • 10% Owner
    		 2,843,849 2009-07-02 0

    PANDYA HEMANSHU PRESIDENT & CEO

    • Officer
    • Director
    		 0 2009-06-29 0

    LIFE SCIENCES OPPORTUNITIES FUND II LP

    LIFE SCIENCES OPPORTUNITIES FUND INSTITTUTIONAL II LP

    LOF PARTNERS LLC

    SMH CAPITAL INC.

    SANDERS MORRIS HARRIS GROUP INC

    GALE JAMES C

    ERONY JOYCE

    MORRIS BENJAMIN T

    • Director
    • 10% Owner
    		 0 2009-05-15 0

    LIFE SCIENCES OPPORTUNITIES FUND II LP

    LOF PARTNERS LLC

    SMH CAPITAL INC.

    SANDERS MORRIS HARRIS GROUP INC

    GALE JAMES C

    ERONY JOYCE

    MORRIS BENJAMIN T

    • Director
    • 10% Owner
    		 0 2009-03-13 0

    KOSTKA JUSTINE ASSISTANT CONTROLLER

    • Officer
    		 0 2008-10-03 0

    MATHUR RAJIV PRESIDENT AND CEO

    • Officer
    • Director
    		 0 2008-02-06 0

    LLOYD CARLENE ANN VICE PRESIDENT OF FINANCE

    • Officer
    		 1,993 2007-06-28 0

    PHARMACHEM LABORATORIES INC

    • 10% Owner
    		 1,500,000 2007-03-07 0

    PAI SUNIL K

    • Director
    		 15,000 2006-07-10 0

    Insider Transactions Last 60 Days

    Reporting Owners Filing Date Trans Date Trans Code Shares Share Price Acquired
    Disposed    		 Shares Owned after D/I 10b5 Perf 1d* Perf 5d* Perf 1m* Max Gain Max Gain Days Max Loss Max Loss Days
    No current insider transactions

    * -

    Transaction Code Definitions
    Code Definition
    A Grant, award or other acquisition pursuant to Rule 16b-3(d)
    C Conversion of derivative security
    D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e)
    E Expiration of short derivative position
    F Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3
    G Bona fide gift
    H Expiration (or cancellation) of long derivative position with value received
    I Discretionary transaction in accordance with Rule 16b-3(f) resulting in acquisition or disposition of issuer securities
    J Other acquisition or disposition
    L Small acquisition under Rule 16a-6
    M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3
    O Exercise of out-of-the-money derivative security
    P Open market or private purchase of non-derivative or derivative security
    S Open market or private sale of non-derivative or derivative security
    U Disposition pursuant to a tender of shares in a change of control transaction
    W Acquisition or disposition by will or the laws of descent and distribution
    X Exercise of in-the-money or at-the-money derivative security
    Z Deposit into or withdrawal from voting trust

    IBR Securities Loan Availability

    Updated throughout the day, this shows the number of shares available to borrow. Data provided by Interactive Brokers

    Security Date/Time Rebate Rate Fee Rate Shares Available
    TELIGENT INC TLGTQ 2021-11-05 12:45:03 UTC -28.7646 28.8346 3000000
    TELIGENT INC TLGTQ 2021-11-04 22:15:03 UTC -28.7646 28.8346 3500000
    TELIGENT INC TLGTQ 2021-11-04 21:45:03 UTC -28.7646 28.8346 3500000
    TELIGENT INC TLGTQ 2021-11-04 21:15:03 UTC -28.7646 28.8346 3500000
    TELIGENT INC TLGTQ 2021-11-04 20:45:04 UTC -28.7646 28.8346 3500000
    TELIGENT INC TLGTQ 2021-11-04 20:15:03 UTC -28.7646 28.8346 3500000
    TELIGENT INC TLGTQ 2021-11-04 19:45:03 UTC -28.7646 28.8346 3500000
    TELIGENT INC TLGTQ 2021-11-04 19:15:03 UTC -28.7646 28.8346 3500000
    TELIGENT INC TLGTQ 2021-11-04 18:45:03 UTC -28.7646 28.8346 3500000
    TELIGENT INC TLGTQ 2021-11-04 18:15:03 UTC -28.7646 28.8346 3400000
    TELIGENT INC TLGTQ 2021-11-04 17:45:03 UTC -28.7646 28.8346 3500000
    TELIGENT INC TLGTQ 2021-11-04 17:15:03 UTC -28.7646 28.8346 3500000
    TELIGENT INC TLGTQ 2021-11-04 16:45:03 UTC -28.7646 28.8346 3500000
    TELIGENT INC TLGTQ 2021-11-04 16:15:03 UTC -28.7646 28.8346 3500000
    TELIGENT INC TLGTQ 2021-11-04 15:45:03 UTC -28.7646 28.8346 3500000
    TELIGENT INC TLGTQ 2021-11-04 15:15:53 UTC -28.7646 28.8346 3500000
    TELIGENT INC TLGTQ 2021-11-04 14:45:03 UTC -28.7646 28.8346 3500000
    TELIGENT INC TLGTQ 2021-11-04 14:15:04 UTC -28.7646 28.8346 3500000
    TELIGENT INC TLGTQ 2021-11-04 13:45:03 UTC -28.7646 28.8346 3500000
    TELIGENT INC TLGTQ 2021-11-04 13:15:03 UTC -28.7646 28.8346 3500000

    Current Active Short Positions

    Holder Issuer Net Short Position Position Date Origin

    No recent transactions

    *** To see all congressional transactions (since 2022) for this stock, please use the congressional transaction search page***

    Elevate your investments